Search Within

ATRIAL FIBRILLATION
High Serum Alkaline Phosphatase Levels in Relation to Multi-Cerebral Microbleeds in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease

Journal: Current Neurovascular Research
Volume: 13,Issue: 4
Page: 303-308
Authors: Junfeng Liu, Deren Wang, Jie Li, Yao Xiong, Bian Liu, Chenchen Wei, Simiao Wu and Ming Liu

Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 19
Page: 2055-2069
Authors: Tatjana S. Potpara, Vera Jokic, Nikolaos Dagres, Torben B. Larsen, Deirdre A. Lane, Gerhard Hindricks and Gregory Y.H. Lip

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban

Journal: Current Cardiology Reviews
Volume: 13,Issue: 1
Page: 41-46
Authors: Kenechukwu Mezue, Chukwudi Obiagwu, Jinu John, Abhishek Sharma, Felix Yang and Jacob Shani

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 15,Issue: 2
Page: 97-100
Authors: Uzair Ansari, Michael Behnes, Christian Fastner and Ibrahim Akin

Atrial Fibrillation: Epidemiology and Peculiarities in the Elderly

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 72-77
Authors: Rose Mary Ferreira Lisboa da Silva

A Review of Hypertension Management in Atrial Fibrillation

Journal: Current Hypertension Reviews
Volume: 12,Issue: 3
Page: 196-202
Authors: Sidakpal S. Panaich, Nilay Patel, Kanishk Agnihotri, Shilpkumar Arora, Chirag Savani, Nileshkumar J. Patel, Samir V. Patel, Rajesh Sonani, Achint Patel, Sopan Lahewala, Vikas Singh, Badal Thakkar, Parth Bhatt, Abhishek Deshmukh and Apurva O. Badheka

The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 3
Page: 260-265
Authors: Beata Franczyk, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, Maciej Banach and Jacek Rysz

NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?

Journal: Recent Advances in Cardiovascular Drug Discovery (Discontinued)
Volume: 10,Issue: 1
Page: 60-64
Authors: Ioannis Merinopoulos, Paul Venables, Isobel Chalmers and Vassilios Vassiliou

Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For Women

Journal: Current Vascular Pharmacology
Volume: 13,Issue: 6
Page: 738-748
Authors: Stefania Basili, Valeria Raparelli, Marco Proietti, Laura Napoleone, Patrizia Ferroni and Flavia Franconi

Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 13
Page: 1896-1903
Authors: Manolis Vavuranakis, Angelos–Michail Kolokathis, Dimitrios A. Vrachatis, Konstantinos Kalogeras, Nikolaos A. Magkoutis, Sabi Fradi, Saïd Ghostine, Marianna Karamanou and Dimitrios Tousoulis

Preoperative Plasma Aldosterone Levels and Postoperative Atrial Fibrillation Occurrence Following Cardiac Surgery: A Review of Literature and Design of the ALDO-POAF Study (ALDOsterone for Prediction of Post-Operative Atrial Fibrillation)

Journal: Current Clinical Pharmacology
Volume: 11,Issue: 3
Page: 150-158
Authors: Mathieu Chequel, Pierre Ollitrault, Eric Saloux, Jean-Jacques Parienti, Marc-Olivier Fischer, Julien Desgué, Stéphane Allouche, Paul Milliez and Joachim Alexandre

Atrial Fibrillation and Gastro-Oesophageal Reflux Disease - Controversies and Challenges

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3829-3834
Authors: Mariana Floria, Oana Barboi, Ciprian Rezus, Valentin Ambarus, Cristina Cijevschi-Prelipcean, Gheorghe Balan and Vasile Liviu Drug

Vernakalant as a Novel Anti-Arrhythmic Agent for Converting of Atrial Fibrillation, Molecular Mechanism, Updated Clinical Efficacy, and Future Development

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 30
Page: 4400-4408
Authors: Shaojie Chen, Shaowen Liu and Helmut Purerfellner

Kv1.5 Inhibitors for Treatment of Atrial Fibrillation: A Tradeoff between Selectivity and Non-selectivity

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 16
Page: 1843-1854
Authors: Xiaoke Guo, Weilin Chen, Haopeng Sun and Qidong You

Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 29
Page: 4604-4609
Authors: Theodoros A. Zografos and Demosthenes G. Katritsis

Previous     Next

Go To   Results 1 - 15 of 224